Prelude Capital Management’s Colgate-Palmolive CL Stock Holding History

Prelude Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-24,000	Closed	-$2.05M	–	1875
2021 Q4	$2.05M	Buy	+24,000	New	+$1.87M	0.05%	308
2018 Q4	–	Sell	-700	Closed	-$47K	–	1814
2018 Q3	$47K	Sell	700 -4,500	-87%	-$300K	﹤0.01%	1141
2018 Q2	$337K	Buy	5,200 +1,900	+58%	+$124K	0.02%	640
2018 Q1	$237K	Buy	+3,300	New	+$237K	0.02%	642

Other funds holding CL

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Prelude Capital Management's CL Position: Q2 2025 in Review

Prelude Capital Management sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 2,409 shares — an estimated $226K sold.

Prelude Capital Management first reported a position in CL in Q2 2013 and held it in 31 quarters. The position peaked at $3.99M in Q2 2020. 1,914 funds tracked by Wall St. Rank hold CL as of Q2 2025.

Prelude Capital Management reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
Prelude Capital Management sold 2,409 Colgate-Palmolive shares in Q2 2025, an estimated $226K.
Prelude Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and held it in 31 quarters.
Prelude Capital Management's Colgate-Palmolive position peaked at $3.99M in Q2 2020.
1,914 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.

Based on Prelude Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.